Table 1. Clinical features according to the type of drainage catheter (including all 371 patients).
c-ENBD (7-Fr) | m-ENBD (6-Fr) | ||
Variables | (n = 242) | (n = 129) | P value |
Age, y (range) | 0.756 | ||
69 (34 – 83) | 68 (35 – 90) | ||
Gender (%) | 0.100 | ||
|
148 (61.2) | 90 (69.8) | |
|
94 (38.8) | 39 (30.2) | |
Bismuth-Corlette criteria, n (%) | 0.040 | ||
|
50 (20.7) | 39 (28.1) | |
|
192 (79.3) | 90 (69.8) | |
Pre-ENBD cholangitis (%) | 0.512 | ||
|
34 (14.0) | 15 (11.6) | |
|
208 (86.0) | 114 (88.4) | |
Pre-ENBD total serum bilirubin (%) | 0.926 | ||
|
95 (39.3) | 50 (38.8) | |
|
147 (60.7) | 79 (61.2) | |
Previous EBS (%) | 0.356 | ||
|
102 (42.1) | 48 (37.2) | |
|
140 (57.9) | 81 (62.8) | |
Previous ENBD (%) | 0.863 | ||
|
43 (17.8) | 22 (17.1) | |
|
199 (82.2) | 107 (82.9) | |
Previous EST (%) | 0.570 | ||
|
84 (34.7) | 41 (31.8) | |
|
158 (65.3) | 88 (68.2) | |
Pancreatography (%) | 0.029 | ||
|
91 (37.6) | 34 (26.4) | |
|
151 (62.4) | 95 (73.6) | |
Duration of ENBD, d (range) | 0.039 | ||
29 (2 – 96) | 33 (3 – 144) | ||
Catheter dislocation (%) | 0.073 | ||
|
6 (2.5) | 8 (6.2) | |
|
236 (97.5) | 121 (93.8) | |
Catheter impaction (%) | 0.071 | ||
|
19 (7.9) | 4 (3.1) | |
|
223 (92.1) | 125 (96.9) | |
Subsequent and/or additional drainage | 0.123 | ||
|
58 (24.0) | 22 (17.1) | |
|
184 (76.0) | 107 (82.9) | |
Post-ENBD cholangitis (%) | 0.006 | ||
|
59 (24.4) | 16 (12.4) | |
|
183 (75.6) | 113 (87.6) | |
Post-ENBD pancreatitis (%) | 0.968 | ||
|
39 (16.1) | 21 (16.3) | |
|
203 (83.9) | 108 (83.7) |
ENBD, endoscopic nasobiliary drainage; c-ENBD, conventional ENBD catheter; m-ENBD, modified ENBD catheter; EBS, endoscopic biliary stenting; EST, endoscopic sphincterotomy